resourceId,resourceName,resourceType,synonyms,rrid,description,aiSummary,usageRequirements,howToAcquire,animalModelId,antibodyId,cellLineId,geneticReagentId,patientDerivedModelId,advancedCellularModelId,computationalToolId,clinicalAssessmentToolId,biobankId,_pmid,_doi,_publicationTitle,_year,_confidence,_toolType
RES7826f166,3D rBM overlay model,Advanced Cellular Model,,,,,,,,,,,,RES7826f166,,,,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.85,advanced_cellular_model
RESe4a3a14d,cNF organoids,Advanced Cellular Model,,,,,,,,,,,,RESe4a3a14d,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,0.95,advanced_cellular_model
REScbf4cfbd,spheroid culture system,Advanced Cellular Model,,,,,,,,,,,,REScbf4cfbd,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,advanced_cellular_model
RES02bbf891,TAME chips,Advanced Cellular Model,,,,,,,,,,,,RES02bbf891,,,,PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,0.85,advanced_cellular_model
RES60a30c1c,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,Animal Model,,,,,,,RES60a30c1c,,,,,,,,,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,0.95,animal_model
RES73ca456b,2.3-kb α1(I) collagen-cre Nf1 flox/flox,Animal Model,,,,,,,RES73ca456b,,,,,,,,,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.85,animal_model
RES25632977,4/FM7; T80-Gal4 y w Mer4,Animal Model,,,,,,,RES25632977,,,,,,,,,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.85,animal_model
RES53af612e,9a−/9a− Nf1,Animal Model,,,,,,,RES53af612e,,,,,,,,,PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,0.9,animal_model
RES6701a540,C57BL6/J Nf1+/−;Trp53+/−,Animal Model,,,,,,,RES6701a540,,,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,0.95,animal_model
RES8010fe38,cisNP,Animal Model,,,,,,,RES8010fe38,,,,,,,,,PMID:38502231 | PMID:34010628,10.1172/JCI176748 | 10.1016/j.stem.2021.04.029,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model
RES67640ce9,"Dhh::Cre, Nf1fl/fl, Pten",Animal Model,,,,,,,RES67640ce9,,,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,animal_model
RES3195007c,DhhCre,Animal Model,,,,,,,RES3195007c,,,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,animal_model
RES8b607c44,DhhCre;Nf1f/f;Luciferase,Animal Model,,,,,,,RES8b607c44,,,,,,,,,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.85,animal_model
RES41704967,DhhCre;Nf1fl/fl,Animal Model,,,,,,,RES41704967,,,,,,,,,PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,,0.95,animal_model
RES51beed64,H7;Nf1mut,Animal Model,,,,,,,RES51beed64,,,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.9,animal_model
RESedb243f5,hGFAP-cre,Animal Model,,,,,,,RESedb243f5,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
RESc188abac,L7-cre,Animal Model,,,,,,,RESc188abac,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
RESc5783883,Math1-cre,Animal Model,,,,,,,RESc5783883,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
RES58594ca6,Nestin-creER,Animal Model,,,,,,,RES58594ca6,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
RES5c29d488,Nf1 c.5425 C > T ; Arg1809Cys,Animal Model,,,,,,,RES5c29d488,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model
RES9aecdcd6,Nf1 f/neo ; hGFAP-Cre,Animal Model,,,,,,,RES9aecdcd6,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model
RES4cf34317,Nf1 fcr,Animal Model,,,,,,,RES4cf34317,,,,,,,,,PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,0.95,animal_model
RESb8ec4fc0,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,Animal Model,,,,,,,RESb8ec4fc0,,,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,animal_model
RESd390084f,Nf1 flox,Animal Model,,,,,,,RESd390084f,,,,,,,,,PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:21726432 | PMID:32839340 | PMID:18242513,10.1002/jcsm.12632 | 10.1002/ajh.22035 | 10.1158/0008-5472.CAN-10-4577 | 10.1186/1741-7015-9-82 | 10.1073/pnas.2008391117 | 10.1016/j.ccr.2008.01.003,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. | Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1. | Brain-wide structural and functional disruption in mice with oligodendrocyte-specific | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,0.95,animal_model
RESe1e3fe79,Nf1 flox/flox ; Hoxb7-Cre,Animal Model,,,,,,,RESe1e3fe79,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model
RESd6ee208c,Nf1 flox/flox; GFAP-Cre,Animal Model,,,,,,,RESd6ee208c,,,,,,,,,PMID:21216928 | PMID:26883872 | PMID:20551058,10.1158/1535-7163.MCT-10-0654 | 10.1016/j.jprot.2016.02.004 | 10.1158/0008-5472.CAN-09-3769,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. | 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,0.95,animal_model
RES9a06a62f,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",Animal Model,,,,,,,RES9a06a62f,,,,,,,,,PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,0.95,animal_model
RES644113d0,Nf1 hGFAP CKO,Animal Model,,,,,,,RES644113d0,,,,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.95,animal_model
RES5b5f1511,Nf1 NcreER CKO,Animal Model,,,,,,,RES5b5f1511,,,,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.9,animal_model
RES136a6220,NF1 R1947/+,Animal Model,,,,,,,RES136a6220,,,,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.95,animal_model
RES18e0d32c,NF1 R1947X minipig,Animal Model,,,,,,,RES18e0d32c,,,,,,,,,PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,0.95,animal_model
RES22a66b69,Nf1(flox/-);Col2.3Cre(+),Animal Model,,,,,,,RES22a66b69,,,,,,,,,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,0.95,animal_model
RES316daddd,Nf1(ob) (-/-),Animal Model,,,,,,,RES316daddd,,,,,,,,,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.9,animal_model
RESd867fbf0,Nf1+/-,Animal Model,,,,,,,RESd867fbf0,,,,,,,,,PMID:32781282 | PMID:21199799 | PMID:8582272 | PMID:21949590 | PMID:40590220 | PMID:36890585 | PMID:40684195 | PMID:23071067 | PMID:26190969 | PMID:21439418 | PMID:25772366 | PMID:29847659 | PMID:18242513 | PMID:28525381 | PMID:16835260 | PMID:18632543,10.1016/j.trsl.2020.08.001 | 10.1158/0008-5472.CAN-10-2732 | 10.1242/dev.121.11.3583 | 10.2478/v10134-010-0025-8 | 10.1172/JCI188932 | 10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1158/0008-5472.CAN-12-1728 | 10.3389/fncel.2015.00234 | 10.1016/j.bone.2011.03.760 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1016/j.ccr.2008.01.003 | 10.18632/oncotarget.17589 | 10.1093/hmg/ddl165 | 10.1001/jama.300.3.287,"Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. | Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. | In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.",,0.95,animal_model
RESfd454e78,Nf1+/− GFAP CKO,Animal Model,,,,,,,RESfd454e78,,,,,,,,,PMID:21963652 | PMID:19191334 | PMID:23225063 | PMID:25772366,10.1016/j.expneurol.2011.09.005 | 10.1002/glia.20845 | 10.1002/ana.23793 | 10.1016/j.celrep.2015.02.041,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,0.95,animal_model
RES70c2125d,Nf1-Arf flox/flox ;Postn-Cre,Animal Model,,,,,,,RES70c2125d,,,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,animal_model
RESae80970f,Nf1-IF,Animal Model,,,,,,,RESae80970f,,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.95,animal_model
RES3a69c7aa,Nf1-IFPS,Animal Model,,,,,,,RES3a69c7aa,,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.95,animal_model
RES95b54f21,Nf1-PS,Animal Model,,,,,,,RES95b54f21,,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.95,animal_model
RESd995ff0b,Nf1/p53-/-,Animal Model,,,,,,,RESd995ff0b,,,,,,,,,PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,0.9,animal_model
RES3dbffed8,Nf1Col1,Animal Model,,,,,,,RES3dbffed8,,,,,,,,,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,0.95,animal_model
RESbb21f572,Nf1Dsk9/+,Animal Model,,,,,,,RESbb21f572,,,,,,,,,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,0.95,animal_model
RESe1def87b,Nf1f/f;Trp53f/f;CGD,Animal Model,,,,,,,RESe1def87b,,,,,,,,,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model
RES92440303,Nf1f/f;Trp53f/f;Nes-TK,Animal Model,,,,,,,RES92440303,,,,,,,,,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model
RES635e34f6,Nf1fl/fl;DhhCre,Animal Model,,,,,,,RES635e34f6,,,,,,,,,PMID:28256556 | PMID:26904939,10.1038/srep43315 | 10.1016/j.celrep.2016.01.074,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,0.95,animal_model
RESbf0146a3,Nf1flox/flox,Animal Model,"Nf1 fl/fl, Nf1 flox/flox, Nf1fl/fl",,,,,,RESbf0146a3,,,,,,,,,PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958 | PMID:34040258,10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1002/glia.20845 | 10.1016/j.bone.2011.03.760 | 10.1117/1.JBO.26.12.125001 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1371/journal.pone.0190001 | 10.18632/oncotarget.17589 | 10.7554/eLife.05151 | 10.1002/jbmr.42 | 10.1038/s41586-021-03580-6,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.95,animal_model
RES027c26cd,Nf1flox/flox; Olig2-Cre,Animal Model,,,,,,,RES027c26cd,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
RES94bdb445,Nf1flox/flox; Prom1-CreER,Animal Model,,,,,,,RES94bdb445,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
RES167f736f,Nf1flox/flox;Arf flox/flox;PostnCre+,Animal Model,,,,,,,RES167f736f,,,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,animal_model
RES971399c4,Nf1flox/flox;PostnCre,Animal Model,,,,,,,RES971399c4,,,,,,,,,PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282,10.1038/s41591-020-01193-6 | 10.1158/1535-7163.MCT-19-0123 | 10.1038/s41416-021-01270-8 | 10.1158/1078-0432.CCR-23-2548,"Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.",,0.95,animal_model
RESc3e4f29b,Nf1flox/mut,Animal Model,,,,,,,RESc3e4f29b,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
RESdab9bd29,Nf1flox/mut; Olig2-Cre,Animal Model,,,,,,,RESdab9bd29,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
RESfdb125d4,Nf1flox/mut; Prom1-CreER,Animal Model,,,,,,,RESfdb125d4,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
RESb35d7371,Nf1flox/mut;GFAP-Cre,Animal Model,,,,,,,RESb35d7371,,,,,,,,,PMID:24375753 | PMID:20551058 | PMID:28525381,10.1002/ana.24093 | 10.1158/0008-5472.CAN-09-3769 | 10.18632/oncotarget.17589,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.95,animal_model
RES7a15e78d,Nf1flox/wt,Animal Model,,,,,,,RES7a15e78d,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
RESe475a58f,Nf1Prx1-/-,Animal Model,,,,,,,RESe475a58f,,,,,,,,,PMID:34935315 | PMID:24465906 | PMID:21726432,10.1117/1.JBO.26.12.125001 | 10.1371/journal.pone.0086115 | 10.1186/1741-7015-9-82,"Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.",,0.95,animal_model
RESa51e3a26,Nf2 flox2/flox2 ;p16 Ink4a*/*,Animal Model,,,,,,,RESa51e3a26,,,,,,,,,PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,0.95,animal_model
RES4be903d5,Nf2+/-,Animal Model,,,,,,,RES4be903d5,,,,,,,,,PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,0.85,animal_model
RES173e403d,Nf2flox/flox,Animal Model,"Nf2 fl/fl, Nf2 flox/flox, Nf2 flox2/flox2, Nf2fl/fl",,,,,,RES173e403d,,,,,,,,,PMID:41444363 | PMID:24817309 | PMID:17924978 | PMID:38945076,10.1038/s41598-025-32031-9 | 10.1371/journal.pone.0097320 | 10.1111/j.1750-3639.2007.00105.x | 10.1016/j.redox.2024.103249,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner. | Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,0.9,animal_model
RESf5e1c690,NPcis,Animal Model,,,,,,,RESf5e1c690,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,animal_model
RESf2783b89,OPG Nf1fl/mut (Nf1+/−),Animal Model,,,,,,,RESf2783b89,,,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.9,animal_model
RES75e5cd5b,Osx-/-Nf1flox/flox,Animal Model,,,,,,,RES75e5cd5b,,,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.85,animal_model
RES0fabb727,"Osx-tTA,tetO-cre;Nf1flox/flox",Animal Model,,,,,,,RES0fabb727,,,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.85,animal_model
RES6f70c029,P0-CRE,Animal Model,,,,,,,RES6f70c029,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.85,animal_model
RESb805ba75,P0SchΔ39-121,Animal Model,,,,,,,RESb805ba75,,,,,,,,,PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,0.95,animal_model
RESa5ded38d,Periostin-CRE;NF2 fl/fl,Animal Model,,,,,,,RESa5ded38d,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,animal_model
RES59ac0b63,Periostin-CRE;NF2 fl/fl TAZ fl/fl,Animal Model,,,,,,,RES59ac0b63,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,animal_model
RESd7bf5ba5,Periostin-CRE;NF2 fl/fl YAP fl/fl,Animal Model,,,,,,,RESd7bf5ba5,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,animal_model
RESe57e7070,PLP CreERT2; Nf1 f/−; ROSA-LacZ,Animal Model,,,,,,,RESe57e7070,,,,,,,,,PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,,0.95,animal_model
RESbcbdd0d7,Postn-Cre; Nf2flox/flox,Animal Model,,,,,,,RESbcbdd0d7,,,,,,,,,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,0.95,animal_model
RESe367efab,Postn-cre;Nf2f/f,Animal Model,,,,,,,RESe367efab,,,,,,,,,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,0.95,animal_model
RES01f5e8c7,P{ KK101909 }VIE‐260B,Animal Model,,,,,,,RES01f5e8c7,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,animal_model
RES37d0d0f4,R681X Nf1,Animal Model,,,,,,,RES37d0d0f4,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,animal_model
RES1e67bb5c,Stat3(fl/fl);Nf1(fl/fl);DhhCre,Animal Model,,,,,,,RES1e67bb5c,,,,,,,,,PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,0.9,animal_model
RESb3e83b3e,TetOff-Osx-/-Nf1,Animal Model,,,,,,,RESb3e83b3e,,,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.9,animal_model
RESc67bdf21,Tg(U6x:nf2a/b-4sgRNA),Animal Model,,,,,,,RESc67bdf21,,,,,,,,,PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,0.95,animal_model
RES9f0896d4,"Trp53, Nf1, Suz12 triple mutant",Animal Model,,,,,,,RES9f0896d4,,,,,,,,,PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,0.95,animal_model
RES64a05ee5,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,Animal Model,,,,,,,RES64a05ee5,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,animal_model
RES6e23a044,y w Mer4,Animal Model,,,,,,,RES6e23a044,,,,,,,,,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.9,animal_model
RESdad6a083,anti-Drosophila neurofibromin,Antibody,,,,,,,,RESe7ee1579,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,antibody
RES58d61189,anti-human neurofibromin,Antibody,,,,,,,,RESb1341551,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,antibody
RES3b6875a5,anti-Merlin,Antibody,,,,,,,,RES1e67e0f9,,,,,,,,PMID:32457840 | PMID:20195187 | PMID:21072183 | PMID:31015291 | PMID:28126595 | PMID:29715273 | PMID:30274821 | PMID:39415595 | PMID:38945076 | PMID:24595234,10.3389/fonc.2020.00687 | 10.1097/MAO.0b013e3181d2777f | 10.1371/journal.pone.0013791 | 10.1126/scisignal.aau8749 | 10.1016/j.ebiom.2017.01.020 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.1242/dmm.050862 | 10.1016/j.redox.2024.103249 | 10.1371/journal.pone.0090853,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling. | Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.",,0.95,antibody
RES107c18b9,anti-neurofibromin,Antibody,,,,,,,,RESb9e87b61,,,,,,,,PMID:38216123 | PMID:38481529 | PMID:37446790 | PMID:39890807 | PMID:29438698 | PMID:29847659 | PMID:36241865,10.1016/j.molmet.2024.101876 | 10.3389/fcell.2024.1359561 | 10.3390/molecules28135128 | 10.1038/s41598-024-84493-y | 10.1016/j.ccell.2018.01.005 | 10.1167/iovs.17-22588 | 10.1038/s12276-022-00850-9,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,0.95,antibody
RES2b858cde,anti-neurofibromin 1,Antibody,,,,,,,,RESbd6927a8,,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.95,antibody
RESe2b2318b,anti-neurofibromin/NF1,Antibody,,,,,,,,RES07ab6ac4,,,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.95,antibody
RESf51f7875,anti-NF1,Antibody,,,,,,,,RESfb1ea3d8,,,,,,,,PMID:41022755 | PMID:28166733 | PMID:38714355 | PMID:39472976 | PMID:41564118 | PMID:30479396 | PMID:39129390 | PMID:34257279 | PMID:34011935 | PMID:25535838,10.1038/s41467-025-63619-4 | 10.1186/s12864-017-3519-7 | 10.1158/1535-7163.MCT-23-0510 | 10.1186/s40478-024-01875-z | 10.1371/journal.pone.0340183 | 10.1038/s41467-018-07452-y | 10.1002/1878-0261.13704 | 10.1038/s41467-021-24505-x | 10.1038/s41419-021-03802-9 | 10.7554/eLife.05151,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.95,antibody
RESebeb2939,anti-NF1GRP-D,Antibody,,,,,,,,REScb3fd620,,,,,,,,PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,0.9,antibody
RES6beaaa76,anti-NF2,Antibody,,,,,,,,RESa1a9bc9f,,,,,,,,PMID:29715273 | PMID:26219339,10.1371/journal.pone.0196726 | 10.18632/oncotarget.4858,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.9,antibody
RES234bae5e,anti-NF2/merlin,Antibody,,,,,,,,RES2fa09c89,,,,,,,,PMID:33273014 | PMID:38216572 | PMID:19144871,10.1074/jbc.RA120.014960 | 10.1038/s41467-024-44755-9 | 10.3181/0809-RM-275,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,0.9,antibody
RES3e27816c,anti-phospho S518-Merlin,Antibody,,,,,,,,RESdd5ecbbb,,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,antibody
RES1cbeb855,anti-phospho-Merlin,Antibody,,,,,,,,RES870ee31a,,,,,,,,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,0.9,antibody
RESb0e57d2a,anti-S518-Merlin,Antibody,,,,,,,,RESacca97fb,,,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,antibody
RESf6f4ae32,anti-SUZ12,Antibody,,,,,,,,RES61579cf6,,,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,0.9,antibody
RESa28a03a6,17,Cell Line,,,,,,,,,RESa28a03a6,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
RES08493b1a,2884,Cell Line,,,,,,,,,RES08493b1a,,,,,,,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,0.9,cell_line
RES9228949e,2885,Cell Line,,,,,,,,,RES9228949e,,,,,,,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,0.9,cell_line
RESd536c7d1,293FT,Cell Line,,,,,,,,,RESd536c7d1,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.85,cell_line
RES63f2af1e,293T,Cell Line,"HEK 293T, HEK-293T, HEK293, HEK293T, NF1-null 293T, NF1-null HEK293T",,,,,,,,REScf18c3c5,,,,,,,PMID:31836666 | PMID:40590220 | PMID:35789380 | PMID:31836666 | PMID:29402968 | PMID:31015291 | PMID:40225167 | PMID:34415582 | PMID:39269317 | PMID:23175151 | PMID:38216587 | PMID:20554030 | PMID:28166733 | PMID:33934112 | PMID:33673681 | PMID:30531922 | PMID:36689660 | PMID:40025578 | PMID:25026211 | PMID:26219339,10.1074/jbc.RA119.010934 | 10.1172/JCI188932 | 10.1158/2159-8290.CD-21-1671 | 10.1074/jbc.RA119.010934 | 10.1038/s41598-018-20894-0 | 10.1126/scisignal.aau8749 | 10.1155/2023/9628049 | 10.1002/glia.24075 | 10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1038/s41467-023-40408-5 | 10.1016/j.jneuroim.2010.05.002 | 10.1186/s12864-017-3519-7 | 10.1038/s41419-021-03716-6 | 10.3390/cancers13050999 | 10.1038/s41591-018-0263-8 | 10.1073/pnas.2208960120 | 10.1186/s40478-025-01965-6 | 10.1016/j.ccr.2014.05.001 | 10.18632/oncotarget.4858,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. | Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of | The molecular landscape of glioma in patients with Neurofibromatosis 1. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.95,cell_line
RES0162cd28,2V6.11,Cell Line,,,,,,,,,RES0162cd28,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.85,cell_line
RES63dfec23,3PNF_SiPSsv_MM_11,Cell Line,,,,,,,,,RES63dfec23,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
RESa015d578,5653,Cell Line,,,,,,,,,RESa015d578,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
RESe4bdb201,5746,Cell Line,,,,,,,,,RESe4bdb201,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
RES82831da4,88-3,Cell Line,,,,,,,,,RES82831da4,,,,,,,PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line
RES4d55b268,90-8,Cell Line,,,,,,,,,RES4d55b268,,,,,,,PMID:24824755 | PMID:20049725 | PMID:32642733 | PMID:18483311,10.1371/journal.pone.0096733 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RESea197438,95.6,Cell Line,,,,,,,,,RESea197438,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,cell_line
RESd602b122,A549,Cell Line,,,,,,,,,RESd602b122,,,,,,,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.85,cell_line
RESc40180a9,AC-CRISPR,Cell Line,,,,,,,,,RESc40180a9,,,,,,,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,0.85,cell_line
RESca37f0db,AC007-hTERT,Cell Line,,,,,,,,,RESca37f0db,,,,,,,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.9,cell_line
RESeae42705,AC028,Cell Line,,,,,,,,,RESeae42705,,,,,,,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.85,cell_line
RES660e82ea,AsPC-1,Cell Line,,,,,,,,,RES660e82ea,,,,,,,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line
RES7ba5993a,B76,Cell Line,,,,,,,,,RES7ba5993a,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
RESb987fd97,B8 fibroblasts,Cell Line,,,,,,,,,RESb987fd97,,,,,,,PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.85,cell_line
RES8ba7d57b,Ben-Men-1,Cell Line,,,,,,,,,RES8ba7d57b,,,,,,,PMID:33273014 | PMID:28126595 | PMID:26219339 | PMID:36148553,10.1074/jbc.RA120.014960 | 10.1016/j.ebiom.2017.01.020 | 10.18632/oncotarget.4858 | 10.1093/brain/awac342,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,cell_line
RES46b2e4c2,BJFF.6,Cell Line,,,,,,,,,RES46b2e4c2,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,cell_line
RES723c52d9,BL21(DE3),Cell Line,,,,,,,,,RES723c52d9,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
RES30a714b9,BL21(DE3) Star,Cell Line,,,,,,,,,RES30a714b9,,,,,,,PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,0.9,cell_line
RES93a28363,BRGN,Cell Line,,,,,,,,,RES93a28363,,,,,,,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.8,cell_line
RESd23e6c85,BxPc3,Cell Line,,,,,,,,,RESd23e6c85,,,,,,,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,cell_line
RES27fb92bc,C2C12,Cell Line,,,,,,,,,RES27fb92bc,,,,,,,PMID:32383545 | PMID:37446790,10.15252/embr.201949117 | 10.3390/molecules28135128,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,0.85,cell_line
RES1aa9a303,CCD-1112Sk,Cell Line,,,,,,,,,RES1aa9a303,,,,,,,PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line
RESbf9e0bf2,cis MPNST,Cell Line,,,,,,,,,RESbf9e0bf2,,,,,,,PMID:38502231 | PMID:35393510,10.1172/JCI176748 | 10.1038/s41418-022-00991-4,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,0.9,cell_line
RESabb7add4,COS-7,Cell Line,,,,,,,,,RESabb7add4,,,,,,,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,0.9,cell_line
RES0bb17402,CT10,Cell Line,,,,,,,,,RES0bb17402,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
RES2566bbac,CT11,Cell Line,,,,,,,,,RES2566bbac,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
RESe416a28a,CT12,Cell Line,,,,,,,,,RESe416a28a,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
RES70f6328b,Daoy,Cell Line,,,,,,,,,RES70f6328b,,,,,,,PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,0.85,cell_line
RES25623437,DBTRG,Cell Line,,,,,,,,,RES25623437,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
RES4ea34695,DDLS,Cell Line,,,,,,,,,RES4ea34695,,,,,,,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.8,cell_line
RESdd4069b7,DH10Bac,Cell Line,,,,,,,,,RESdd4069b7,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
RES036a0bbd,DH5α bacteria,Cell Line,,,,,,,,,RES036a0bbd,,,,,,,PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,0.8,cell_line
REScd43134d,dNF1‐KO,Cell Line,,,,,,,,,REScd43134d,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line
RES65662a6d,Drosophila Schneider (S2R+),Cell Line,,,,,,,,,RES65662a6d,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,cell_line
RESe2bfa3a9,DS-red STS26T,Cell Line,,,,,,,,,RESe2bfa3a9,,,,,,,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RES8e44a7c5,E13.5 DRG neurosphere,Cell Line,,,,,,,,,RES8e44a7c5,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.8,cell_line
RESba34146c,FC-1801,Cell Line,,,,,,,,,RESba34146c,,,,,,,PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,0.9,cell_line
RESd0d2a3a9,FiPS,Cell Line,,,,,,,,,RESd0d2a3a9,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
RES9927ef7e,GBM1,Cell Line,,,,,,,,,RES9927ef7e,,,,,,,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,0.9,cell_line
RESc7b181eb,H1838,Cell Line,,,,,,,,,RESc7b181eb,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
RES6448cbce,H358,Cell Line,,,,,,,,,RES6448cbce,,,,,,,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.8,cell_line
RES83633cde,HEI-193,Cell Line,,,,,,,,,RES83633cde,,,,,,,PMID:21111000 | PMID:38216587 | PMID:30617350 | PMID:30274821,10.1016/j.jneumeth.2010.10.021 | 10.1038/s41467-023-40408-5 | 10.1038/s41596-018-0105-7 | 10.1016/j.ebiom.2018.09.042,"A novel imaging-compatible sciatic nerve schwannoma model. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.",,0.95,cell_line
RES1de4e591,HeLa,Cell Line,,,,,,,,,RES1de4e591,,,,,,,PMID:40590220 | PMID:36420221 | PMID:32383545,10.1172/JCI188932 | 10.1016/j.omtn.2022.10.026 | 10.15252/embr.201949117,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,0.95,cell_line
RESd6afe7f8,HFFs,Cell Line,,,,,,,,,RESd6afe7f8,,,,,,,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line
RES00c86d4a,HPDE H6c7,Cell Line,,,,,,,,,RES00c86d4a,,,,,,,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line
RESb82893e4,HS-PSS,Cell Line,,,,,,,,,RESb82893e4,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
RES871bb6fa,HS-Sch-2,Cell Line,,,,,,,,,RES871bb6fa,,,,,,,PMID:32642733 | PMID:35511749,10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-21-0947,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RESaed6fdb0,HSC1λ,Cell Line,,,,,,,,,RESaed6fdb0,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line
RES0e69a08f,HSR-GBM1,Cell Line,,,,,,,,,RES0e69a08f,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
RESe9e677f7,hTERT ipn02.3 2λ,Cell Line,,,,,,,,,RESe9e677f7,,,,,,,PMID:37140985 | PMID:38127282,10.1172/JCI168227 | 10.1158/1078-0432.CCR-23-2548,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line
RES2fe12b13,hTERT ipn02.3 2λ CRL‐3392,Cell Line,,,,,,,,,RES2fe12b13,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,cell_line
RES487eca0a,hTERT ipNF05.5,Cell Line,,,,,,,,,RES487eca0a,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.95,cell_line
RESa4c9d0d2,hTERT NF1 ipn02.3 2λ,Cell Line,,,,,,,,,RESa4c9d0d2,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line
RES05f18fad,hTERT NF1 ipNF95.6,Cell Line,,,,,,,,,RES05f18fad,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,cell_line
RES9709e143,HTS-Luc MPNST,Cell Line,,,,,,,,,RES9709e143,,,,,,,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.9,cell_line
RES94d99650,Human Foreskin Fibroblast (HFF),Cell Line,,,,,,,,,RES94d99650,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.8,cell_line
RES35bbc5c9,Human meningeal cells (HMC),Cell Line,,,,,,,,,RES35bbc5c9,,,,,,,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,0.85,cell_line
RES8ff373eb,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700)",Cell Line,,,,,,,,,RES8ff373eb,,,,,,,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.9,cell_line
RES2c34b788,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",Cell Line,,,,,,,,,RES2c34b788,,,,,,,PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,0.9,cell_line
RESa6f1e455,Human Schwann cells (HSCs),Cell Line,,,,,,,,,RESa6f1e455,,,,,,,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.85,cell_line
RESa3568ca9,i18cNF,Cell Line,,,,,,,,,RESa3568ca9,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
RESbcad377e,i21cNF,Cell Line,,,,,,,,,RESbcad377e,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
RES0be2e415,i28cNF,Cell Line,,,,,,,,,RES0be2e415,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
RES42459202,icNF00.10a,Cell Line,,,,,,,,,RES42459202,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
RES458b9b4f,icNF04.9a,Cell Line,,,,,,,,,RES458b9b4f,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
RES6156e612,icNF97.2a,Cell Line,,,,,,,,,RES6156e612,,,,,,,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line
RESe3697125,icNF97.2b,Cell Line,,,,,,,,,RESe3697125,,,,,,,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line
RES1f1514dd,icNF98.4c,Cell Line,,,,,,,,,RES1f1514dd,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
RES0583d402,icNF98.4d,Cell Line,,,,,,,,,RES0583d402,,,,,,,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line
RES9da57d39,iHSCs,Cell Line,,,,,,,,,RES9da57d39,,,,,,,PMID:23685747 | PMID:41036607,10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,cell_line
RESfd5f7e36,ipn02.3,Cell Line,,,,,,,,,RESfd5f7e36,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,cell_line
RES22f213dc,ipn023λ,Cell Line,,,,,,,,,RES22f213dc,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
RESc11f75a8,ipn95.11bC,Cell Line,,,,,,,,,RESc11f75a8,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line
RES5718db6a,ipn97.4 immortalized human Schwann,Cell Line,,,,,,,,,RES5718db6a,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,0.9,cell_line
RES0fc58348,ipNF02.3 2λ,Cell Line,,,,,,,,,RES0fc58348,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.85,cell_line
RES9e84f002,ipNF02.8,Cell Line,,,,,,,,,RES9e84f002,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.85,cell_line
RES4029030f,ipNF03.3,Cell Line,,,,,,,,,RES4029030f,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
RES5de742ed,ipNF05.5,Cell Line,,,,,,,,,RES5de742ed,,,,,,,PMID:39129390 | PMID:40862755 | PMID:39061138 | PMID:33658640,10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.3390/cancers16142498 | 10.1038/s41416-021-01270-8,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.95,cell_line
RES27a80654,ipNF05.5 (mixed clone),Cell Line,,,,,,,,,RES27a80654,,,,,,,PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,0.95,cell_line
RESc8a1bf77,ipNF05.5 (single clone),Cell Line,,,,,,,,,RESc8a1bf77,,,,,,,PMID:35741605 | PMID:40723243,10.3390/brainsci12060720 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.95,cell_line
RES21be72dc,ipNF05.5 Mixed Clones,Cell Line,,,,,,,,,RES21be72dc,,,,,,,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.9,cell_line
RES4619f98d,ipNF05.5-MX,Cell Line,,,,,,,,,RES4619f98d,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line
RES2d65bb8e,ipNF06.2A,Cell Line,,,,,,,,,RES2d65bb8e,,,,,,,PMID:37164978 | PMID:38136356,10.1038/s41467-023-38432-6 | 10.3390/cancers15245811,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line
RESdf9174e6,ipNF95.11b C-RFP,Cell Line,,,,,,,,,RESdf9174e6,,,,,,,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.9,cell_line
RES5d59f7d9,ipNF95.11b C/T,Cell Line,,,,,,,,,RES5d59f7d9,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line
RES8555ee4e,ipNF95.11bC,Cell Line,,,,,,,,,RES8555ee4e,,,,,,,PMID:35741605 | PMID:39129390 | PMID:40862755 | PMID:36689660 | PMID:39061138 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.1073/pnas.2208960120 | 10.3390/cancers16142498 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.95,cell_line
RES53c1db9a,ipNF95.6,Cell Line,,,,,,,,,RES53c1db9a,,,,,,,PMID:35741605 | PMID:33934112 | PMID:33442015 | PMID:38136356,10.3390/brainsci12060720 | 10.1038/s41419-021-03716-6 | 10.1038/s41591-020-01193-6 | 10.3390/cancers15245811,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.95,cell_line
RES5e08b0cc,ipnNF09.4,Cell Line,,,,,,,,,RES5e08b0cc,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line
RESd7276863,ipnNF95.11c,Cell Line,,,,,,,,,RESd7276863,,,,,,,PMID:35741605 | PMID:39129390 | PMID:38136356 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cancers15245811 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.95,cell_line
RES0f0c862a,iSC,Cell Line,,,,,,,,,RES0f0c862a,,,,,,,PMID:38201517 | PMID:18367665,10.3390/cancers16010089 | 10.1124/jpet.107.135830,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.9,cell_line
RES06bbbd46,JH-2-002,Cell Line,,,,,,,,,RES06bbbd46,,,,,,,PMID:38000020 | PMID:38127282 | PMID:33032988,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548 | 10.1158/0008-5472.CAN-20-1365,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RES748525c7,JH-2-031,Cell Line,,,,,,,,,RES748525c7,,,,,,,PMID:38000020 | PMID:33032988,10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RES24aca845,JH-2-079c,Cell Line,,,,,,,,,RES24aca845,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RES76c34922,JH-2-103,Cell Line,,,,,,,,,RES76c34922,,,,,,,PMID:38000020 | PMID:38127282,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line
RESf06dbe60,JH-2–009,Cell Line,,,,,,,,,RESf06dbe60,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
RES7ca5dafd,JH-2–055,Cell Line,,,,,,,,,RES7ca5dafd,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
RES6eacdbed,JH-2–060,Cell Line,,,,,,,,,RES6eacdbed,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
RESa6c2ea92,JH-2–074,Cell Line,,,,,,,,,RESa6c2ea92,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
RES2261022f,JH-2–077,Cell Line,,,,,,,,,RES2261022f,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
RESbd60dbd9,JHH-0879,Cell Line,,,,,,,,,RESbd60dbd9,,,,,,,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,0.9,cell_line
RESe586e098,JHH-136,Cell Line,,,,,,,,,RESe586e098,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
RES7d16532b,JHH-520,Cell Line,,,,,,,,,RES7d16532b,,,,,,,PMID:39472976 | PMID:38714355,10.1186/s40478-024-01875-z | 10.1158/1535-7163.MCT-23-0510,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.95,cell_line
RES7cfe241c,JHU-0879,Cell Line,,,,,,,,,RES7cfe241c,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
RESd39ec166,JHU-1016B,Cell Line,,,,,,,,,RESd39ec166,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
RES9723ccfe,JW18.2,Cell Line,,,,,,,,,RES9723ccfe,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.85,cell_line
RES80dcb249,JW23.3,Cell Line,,,,,,,,,RES80dcb249,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.85,cell_line
RESdb3ab40e,K4622 grade II glioma,Cell Line,,,,,,,,,RESdb3ab40e,,,,,,,PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,0.9,cell_line
RESfdd6b370,K562,Cell Line,,,,,,,,,RESfdd6b370,,,,,,,PMID:23685747 | PMID:40025578,10.1038/ng.2641 | 10.1186/s40478-025-01965-6,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line
RESb1b27a6d,KT21-MG1,Cell Line,,,,,,,,,RESb1b27a6d,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,cell_line
RES98351e60,LLC-PK1 ATCC CL-101,Cell Line,,,,,,,,,RES98351e60,,,,,,,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,0.85,cell_line
RESec88ccdf,LN229,Cell Line,,,,,,,,,RESec88ccdf,,,,,,,PMID:41022755 | PMID:38714355,10.1038/s41467-025-63619-4 | 10.1158/1535-7163.MCT-23-0510,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
RESecb75ef8,LN319,Cell Line,,,,,,,,,RESecb75ef8,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,cell_line
RES6e47acf7,LN428 human glioblastoma multiforme (GBM),Cell Line,,,,,,,,,RES6e47acf7,,,,,,,PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,0.85,cell_line
RES310ed0e3,LS141,Cell Line,,,,,,,,,RES310ed0e3,,,,,,,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.8,cell_line
RESbb2011d5,LUVA,Cell Line,,,,,,,,,RESbb2011d5,,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.85,cell_line
RESb9449add,lymphoblastoid,Cell Line,,,,,,,,,RESb9449add,,,,,,,PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,0.85,cell_line
RESa3b8883e,M1,Cell Line,,,,,,,,,RESa3b8883e,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
RESdc69ceb0,M3,Cell Line,,,,,,,,,RESdc69ceb0,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
RESa889216f,M308,Cell Line,,,,,,,,,RESa889216f,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
RESd9806b0b,M4,Cell Line,,,,,,,,,RESd9806b0b,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
RESa330fc30,M5,Cell Line,,,,,,,,,RESa330fc30,,,,,,,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line
RES15880533,M6,Cell Line,,,,,,,,,RES15880533,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
RES0b303b9d,M724,Cell Line,,,,,,,,,RES0b303b9d,,,,,,,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line
RES13ccb15b,MCF10A,Cell Line,,,,,,,,,RES13ccb15b,,,,,,,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.85,cell_line
RES1945f01f,MCF7,Cell Line,,,,,,,,,RES1945f01f,,,,,,,PMID:38216123 | PMID:40507334,10.1016/j.molmet.2024.101876 | 10.3390/cancers17111852,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,0.9,cell_line
RES7ec195a8,Meso-33,Cell Line,,,,,,,,,RES7ec195a8,,,,,,,PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,0.9,cell_line
RES3224a315,MiaPaCa-2,Cell Line,,,,,,,,,RES3224a315,,,,,,,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,cell_line
RESd4d873f7,MN1-LF,Cell Line,,,,,,,,,RESd4d873f7,,,,,,,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,0.85,cell_line
RES2ab2c141,mouse embryonic fibroblasts (MEFs),Cell Line,,,,,,,,,RES2ab2c141,,,,,,,PMID:28392281 | PMID:34065204,10.1016/j.expneurol.2017.04.001 | 10.3390/ijms22105367,Human stem cell modeling in neurofibromatosis type 1 (NF1). | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,0.9,cell_line
RESeb9e3bd3,"Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",Cell Line,,,,,,,,,RESeb9e3bd3,,,,,,,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.9,cell_line
RES8bfa4d28,MPNST,Cell Line,,,,,,,,,RES8bfa4d28,,,,,,,PMID:24509877 | PMID:18413802,10.1038/onc.2013.506 | 10.1158/1535-7163.MCT-07-0518,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.9,cell_line
RES8fea907c,MPNST 88-14,Cell Line,,,,,,,,,RES8fea907c,,,,,,,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.95,cell_line
RES6703798b,MPNST S462-TY,Cell Line,,,,,,,,,RES6703798b,,,,,,,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.95,cell_line
RESebfbb29f,MPNST-NF1-08,Cell Line,,,,,,,,,RESebfbb29f,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RES62b59d33,MPNST-NF1-9,Cell Line,,,,,,,,,RES62b59d33,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RESf6ce18b7,MPNST-SP-01,Cell Line,,,,,,,,,RESf6ce18b7,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RESfc99283a,MPNST642,Cell Line,,,,,,,,,RESfc99283a,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line
RESd6bdbe98,murine NF2 −/− Schwann,Cell Line,,,,,,,,,RESd6bdbe98,,,,,,,PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,0.9,cell_line
RES32251ebd,NCI-H266,Cell Line,,,,,,,,,RES32251ebd,,,,,,,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line
RES7b2e113f,Neural stem,Cell Line,,,,,,,,,RES7b2e113f,,,,,,,PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,0.8,cell_line
RES015a8eda,Neurofibromatosis 1 fibroblasts,Cell Line,,,,,,,,,RES015a8eda,,,,,,,PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,0.85,cell_line
RESc0c71d85,NF02.2,Cell Line,,,,,,,,,RESc0c71d85,,,,,,,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RESd9a729dd,Nf1 flox/flox calvaria osteoblasts,Cell Line,,,,,,,,,RESd9a729dd,,,,,,,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.8,cell_line
RESc5815f89,NF1-/- iPSC-derived neural crest,Cell Line,,,,,,,,,RESc5815f89,,,,,,,PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,0.85,cell_line
RESabd0cc70,Nf1-/- mouse embryo fibroblasts,Cell Line,,,,,,,,,RESabd0cc70,,,,,,,PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,0.9,cell_line
REScb018edb,NF1-1 hiPSC line,Cell Line,,,,,,,,,REScb018edb,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.9,cell_line
RES44e8d8f6,NF1-2 hiPSC line,Cell Line,,,,,,,,,RES44e8d8f6,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.9,cell_line
RES8cd5f20e,NF10.1,Cell Line,,,,,,,,,RES8cd5f20e,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
RES437abbbb,NF11.1,Cell Line,,,,,,,,,RES437abbbb,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
RES3e51adf0,Nf1flox/flox bone marrow stromal,Cell Line,,,,,,,,,RES3e51adf0,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.8,cell_line
RESdc14408d,"NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12",Cell Line,,,,,,,,,RESdc14408d,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
RES33a9f0e9,NF2 primary fibroblasts,Cell Line,,,,,,,,,RES33a9f0e9,,,,,,,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,0.9,cell_line
RES07add6ac,Nf2-deficient spinal cord neural progenitor,Cell Line,,,,,,,,,RES07add6ac,,,,,,,PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,0.9,cell_line
RESbaf0c6ad,NF37,Cell Line,,,,,,,,,RESbaf0c6ad,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
RES4f830669,NF87,Cell Line,,,,,,,,,RES4f830669,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
RES7d84433c,NF90-8,Cell Line,,,,,,,,,RES7d84433c,,,,,,,PMID:18367665 | PMID:33658640 | PMID:33032988,10.1124/jpet.107.135830 | 10.1038/s41416-021-01270-8 | 10.1158/0008-5472.CAN-20-1365,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.95,cell_line
RESae0432c8,NF94.3,Cell Line,,,,,,,,,RESae0432c8,,,,,,,PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RESf59f8ed8,NF95.11b,Cell Line,,,,,,,,,RESf59f8ed8,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line
RES250e44b5,NF95.6,Cell Line,,,,,,,,,RES250e44b5,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line
RES68239221,NF96.2,Cell Line,,,,,,,,,RES68239221,,,,,,,PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
RES8d501cc9,NGT-41,Cell Line,,,,,,,,,RES8d501cc9,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
RES331e6cdf,NIH-3T3,Cell Line,,,,,,,,,RES331e6cdf,,,,,,,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,0.9,cell_line
RES240e5436,NMCG-1,Cell Line,,,,,,,,,RES240e5436,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
RES6382be4a,Normal human Schwann cells (HSC),Cell Line,,,,,,,,,RES6382be4a,,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,0.85,cell_line
RESb2bfc67f,Normal human Schwann cells (NHSC),Cell Line,,,,,,,,,RESb2bfc67f,,,,,,,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.85,cell_line
RES2b525570,Normal human Schwann cells (Sciencell),Cell Line,,,,,,,,,RES2b525570,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,cell_line
RES63492a0a,NPcis,Cell Line,,,,,,,,,RES63492a0a,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,0.95,cell_line
RESce5c25bd,NSF1,Cell Line,,,,,,,,,RESce5c25bd,,,,,,,PMID:41001593 | PMID:32948135,10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.9,cell_line
RES33b4d8cc,OLN93 mouse oligodendrocyte,Cell Line,,,,,,,,,RES33b4d8cc,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line
RES5ca9707b,optic glioma,Cell Line,,,,,,,,,RES5ca9707b,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.8,cell_line
RES928f1713,PANC1,Cell Line,,,,,,,,,RES928f1713,,,,,,,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,cell_line
RES828ab613,PNF-derived Schwann,Cell Line,,,,,,,,,RES828ab613,,,,,,,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,0.85,cell_line
RESd2d7bbb3,pNF9511bc,Cell Line,,,,,,,,,RESd2d7bbb3,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
RESe7efd56d,primary human Schwann cells (HSC),Cell Line,,,,,,,,,RESe7efd56d,,,,,,,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.85,cell_line
RESf476bcb6,Primary human vestibular schwannoma (VS) cell cultures,Cell Line,,,,,,,,,RESf476bcb6,,,,,,,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,0.9,cell_line
RES4140cd3d,Primary normal rat Schwann,Cell Line,,,,,,,,,RES4140cd3d,,,,,,,PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.85,cell_line
RESbf7021d2,RHT92,Cell Line,,,,,,,,,RESbf7021d2,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
RES40c42020,Rosetta2(DE3) competent,Cell Line,,,,,,,,,RES40c42020,,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,0.85,cell_line
RES8053683d,RT4-D6P2T schwannoma,Cell Line,,,,,,,,,RES8053683d,,,,,,,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.9,cell_line
RESc23eadf1,RT4-D6PT2 schwannoma,Cell Line,,,,,,,,,RESc23eadf1,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line
RES7787dd40,S462,Cell Line,,,,,,,,,RES7787dd40,,,,,,,PMID:41022755 | PMID:32383545 | PMID:33658640 | PMID:38502231 | PMID:23328114 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:41001593 | PMID:32948135 | PMID:37410426 | PMID:23535903 | PMID:35511749,10.1038/s41467-025-63619-4 | 10.15252/embr.201949117 | 10.1038/s41416-021-01270-8 | 10.1172/JCI176748 | 10.18632/oncotarget.793 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947,"Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.",,0.95,cell_line
RESba144dfb,S462TY,Cell Line,,,,,,,,,RESba144dfb,,,,,,,PMID:38201517 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:41036607 | PMID:38203448 | PMID:23535903,10.3390/cancers16010089 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.95,cell_line
RESeba89533,S520,Cell Line,,,,,,,,,RESeba89533,,,,,,,PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RES4bb1d196,SC4-immortalized Nf2-/- primary Schwann,Cell Line,,,,,,,,,RES4bb1d196,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.95,cell_line
RES4bc847e6,Schwann,Cell Line,,,,,,,,,RES4bc847e6,,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.9,cell_line
RES649a81c4,Sf9,Cell Line,,,,,,,,,RES649a81c4,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
RES359bb0bd,SNF02.2,Cell Line,,,,,,,,,RES359bb0bd,,,,,,,PMID:29438698 | PMID:38216572,10.1016/j.ccell.2018.01.005 | 10.1038/s41467-024-44755-9,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.95,cell_line
RES920f4fcf,SNF94.3,Cell Line,,,,,,,,,RES920f4fcf,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line
RES65ffa5bf,SNF96.2,Cell Line,,,,,,,,,RES65ffa5bf,,,,,,,PMID:39269317 | PMID:23175151 | PMID:29438698 | PMID:40025578 | PMID:36322658 | PMID:35511749 | PMID:32642733 | PMID:38216572,10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1016/j.ccell.2018.01.005 | 10.1186/s40478-025-01965-6 | 10.1126/sciadv.abo5442 | 10.1158/1535-7163.MCT-21-0947 | 10.1093/noajnl/vdz061 | 10.1038/s41467-024-44755-9,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.95,cell_line
RES8c79577c,ST88-14,Cell Line,,,,,,,,,RES8c79577c,,,,,,,PMID:38201517 | PMID:41022755 | PMID:39269317 | PMID:18367665 | PMID:37246765 | PMID:33658640 | PMID:24824755 | PMID:39129390 | PMID:18413802 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:38216572 | PMID:38203448 | PMID:23535903 | PMID:41036607 | PMID:33032988,10.3390/cancers16010089 | 10.1038/s41467-025-63619-4 | 10.1158/1078-0432.CCR-24-1750 | 10.1124/jpet.107.135830 | 10.1093/neuonc/noad097 | 10.1038/s41416-021-01270-8 | 10.1371/journal.pone.0096733 | 10.1002/1878-0261.13704 | 10.1158/1535-7163.MCT-07-0518 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1038/s41467-024-44755-9 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-24-1053 | 10.1158/0008-5472.CAN-20-1365,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,0.95,cell_line
RES8fd7beb2,ST88-3,Cell Line,,,,,,,,,RES8fd7beb2,,,,,,,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RES74567322,STS26T,Cell Line,,,,,,,,,RES74567322,,,,,,,PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38203448 | PMID:37410426 | PMID:23535903 | PMID:35511749 | PMID:33032988,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.3390/ijms25010277 | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947 | 10.1158/0008-5472.CAN-20-1365,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,0.9,cell_line
RES46d7227b,T265,Cell Line,,,,,,,,,RES46d7227b,,,,,,,PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:41001593 | PMID:38203448 | PMID:32948135 | PMID:23535903,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1080/23723556.2025.2561292 | 10.3390/ijms25010277 | 10.1186/s12885-020-07397-w | 10.1158/2159-8290.CD-13-0081,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.9,cell_line
RES7d7c375d,T265-2c,Cell Line,,,,,,,,,RES7d7c375d,,,,,,,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,0.9,cell_line
REScea4eddb,T265p21,Cell Line,,,,,,,,,REScea4eddb,,,,,,,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RESd8d494a3,T98G,Cell Line,,,,,,,,,RESd8d494a3,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.8,cell_line
RES642f055b,tail-tip fibroblasts (TTFs),Cell Line,,,,,,,,,RES642f055b,,,,,,,PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,0.9,cell_line
RES6b2e8a99,TC620 human oligodendroglioma,Cell Line,,,,,,,,,RES6b2e8a99,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line
RES7b299c69,TM-31,Cell Line,,,,,,,,,RES7b299c69,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
RESfe968e38,Tni-FNL,Cell Line,,,,,,,,,RESfe968e38,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
RES64383697,TOP-10F',Cell Line,,,,,,,,,RES64383697,,,,,,,PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,0.85,cell_line
RES874fed52,U251,Cell Line,,,,,,,,,RES874fed52,,,,,,,PMID:32419643 | PMID:33934112 | PMID:25043298,10.1177/1533033820919759 | 10.1038/s41419-021-03716-6 | 10.1038/onc.2014.185,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,cell_line
RES0242f8da,U2OS,Cell Line,,,,,,,,,RES0242f8da,,,,,,,PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,0.85,cell_line
RES02cd4945,U87-MG,Cell Line,,,,,,,,,RES02cd4945,,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,0.95,cell_line
RES2a6648a2,WM3918,Cell Line,,,,,,,,,RES2a6648a2,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
RES71ae386c,WT-1 hiPSC line,Cell Line,,,,,,,,,RES71ae386c,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.85,cell_line
RES637f1fbc,WT-2 hiPSC line,Cell Line,,,,,,,,,RES637f1fbc,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.85,cell_line
RESc41540f6,YST1,Cell Line,,,,,,,,,RESc41540f6,,,,,,,PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
RES27693bb3,φNX packaging,Cell Line,,,,,,,,,RES27693bb3,,,,,,,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,0.85,cell_line
RES3d1c5b79,BoN (Burden of NF1) questionnaire,Clinical Assessment Tool,,,,,,,,,,,,,,RES3d1c5b79,,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.95,clinical_assessment_tool
RES9cacf8bc,Cardiff acuity cards,Clinical Assessment Tool,,,,,,,,,,,,,,RES9cacf8bc,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
RESa1301f77,Cirrus HD-OCT,Clinical Assessment Tool,,,,,,,,,,,,,,RESa1301f77,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool
RES957dce31,cNF-Skindex,Clinical Assessment Tool,,,,,,,,,,,,,,RES957dce31,,PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,0.95,clinical_assessment_tool
RESa9713e90,Dermatology Life Quality Index (DLQI),Clinical Assessment Tool,,,,,,,,,,,,,,RESa9713e90,,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.9,clinical_assessment_tool
RESce67dd2f,Humphrey Field Analyzer perimetry,Clinical Assessment Tool,,,,,,,,,,,,,,RESce67dd2f,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool
RESeffc3820,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire,Clinical Assessment Tool,,,,,,,,,,,,,,RESeffc3820,,PMID:28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,,0.95,clinical_assessment_tool
RES52bd88fc,KM (Konstantin Moutakis) cards,Clinical Assessment Tool,,,,,,,,,,,,,,RES52bd88fc,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
RESdb522b86,Lea cards,Clinical Assessment Tool,,,,,,,,,,,,,,RESdb522b86,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
RES19135a16,Likert scale questionnaire,Clinical Assessment Tool,,,,,,,,,,,,,,RES19135a16,,PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,0.85,clinical_assessment_tool
RES6496c902,PlexiQoL,Clinical Assessment Tool,,,,,,,,,,,,,,RES6496c902,,PMID:33085177 | PMID:38499890,10.1002/mgg3.1530 | 10.1186/s41687-024-00714-y,"The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas. | The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,0.95,clinical_assessment_tool
RES0f6ab480,SF12,Clinical Assessment Tool,,,,,,,,,,,,,,RES0f6ab480,,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.9,clinical_assessment_tool
REScf856181,Teller acuity cards,Clinical Assessment Tool,,,,,,,,,,,,,,REScf856181,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
RESc9cd8d77,World Health Organization Categories of Childhood VI scale,Clinical Assessment Tool,,,,,,,,,,,,,,RESc9cd8d77,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool
RESda500560,DINs (Deep Interactive Networks),Computational Tool,,,,,,,,,,,,,RESda500560,,,PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,0.95,computational_tool
RES5b11eb44,RENOVO-NF1,Computational Tool,,,,,,,,,,,,,RES5b11eb44,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,0.95,computational_tool
RESdfd13d05,1276P NF1 GRD,Genetic Reagent,,,,,,,,,,RESdfd13d05,,,,,,PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,0.9,genetic_reagent
RES0829546a,Cas9 and sgRNAs targeting Nf1+Cdkn2a,Genetic Reagent,,,,,,,,,,RES0829546a,,,,,,PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,0.9,genetic_reagent
RESdcd0e8c4,dNf1,Genetic Reagent,,,,,,,,,,RESdcd0e8c4,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,genetic_reagent
RESd9daee7e,HA-Merlin,Genetic Reagent,,,,,,,,,,RESd9daee7e,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,genetic_reagent
RES3c86e21c,human neurofibromin,Genetic Reagent,,,,,,,,,,RES3c86e21c,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.95,genetic_reagent
RES11f352ff,Merlin,Genetic Reagent,,,,,,,,,,RES11f352ff,,,,,,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,genetic_reagent
RES23b2c1c0,Merlin isoform 1,Genetic Reagent,,,,,,,,,,RES23b2c1c0,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,0.85,genetic_reagent
RESf0456171,Merlin siRNA,Genetic Reagent,,,,,,,,,,RESf0456171,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.85,genetic_reagent
RES2f3f2a53,Merlin(S518D) and Merlin(S518E) mutants,Genetic Reagent,,,,,,,,,,RES2f3f2a53,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,0.8,genetic_reagent
RESf228eeaf,neurofibromin 2,Genetic Reagent,,,,,,,,,,RESf228eeaf,,,,,,PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,0.95,genetic_reagent
RES5b74c968,Nf1,Genetic Reagent,,,,,,,,,,RES5b74c968,,,,,,PMID:32461556 | PMID:38481529 | PMID:39890807 | PMID:34646065 | PMID:37446790 | PMID:34011935 | PMID:29670214 | PMID:37140985 | PMID:36241865,10.1038/s41467-020-16432-0 | 10.3389/fcell.2024.1359561 | 10.1038/s41598-024-84493-y | 10.1155/2021/9386823 | 10.3390/molecules28135128 | 10.1038/s41419-021-03802-9 | 10.1038/s41598-018-24310-5 | 10.1172/JCI168227 | 10.1038/s12276-022-00850-9,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Survival and | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Restoring functional neurofibromin by protein transduction. | Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,0.95,genetic_reagent
RESb42186d8,NF1 capture probes,Genetic Reagent,,,,,,,,,,RESb42186d8,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,0.9,genetic_reagent
RES635b74af,NF1 DLR,Genetic Reagent,,,,,,,,,,RES635b74af,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.95,genetic_reagent
RESc54d4fe5,Nf1 flox,Genetic Reagent,,,,,,,,,,RESc54d4fe5,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.95,genetic_reagent
RES97ca2fea,NF1 gRNA,Genetic Reagent,,,,,,,,,,RES97ca2fea,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.85,genetic_reagent
RES4701a839,NF1 isoform 2,Genetic Reagent,,,,,,,,,,RES4701a839,,,,,,PMID:31836666 | PMID:36689660,10.1074/jbc.RA119.010934 | 10.1073/pnas.2208960120,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,0.9,genetic_reagent
RES42a9482e,Nf1 KO,Genetic Reagent,,,,,,,,,,RES42a9482e,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.9,genetic_reagent
RESe1af3877,NF1-GRD,Genetic Reagent,,,,,,,,,,RESe1af3877,,,,,,PMID:24509877 | PMID:35393510 | PMID:16835260 | PMID:38000020,10.1038/onc.2013.506 | 10.1038/s41418-022-00991-4 | 10.1093/hmg/ddl165 | 10.1126/sciadv.adg8876,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,genetic_reagent
RES17bd5adf,NF1-targeting TALEN,Genetic Reagent,,,,,,,,,,RES17bd5adf,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.85,genetic_reagent
RESc7f2e43a,NF2,Genetic Reagent,,,,,,,,,,RESc7f2e43a,,,,,,PMID:33273014 | PMID:29715273 | PMID:30274821 | PMID:26219339 | PMID:24595234,10.1074/jbc.RA120.014960 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.18632/oncotarget.4858 | 10.1371/journal.pone.0090853,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.9,genetic_reagent
RES0c4385ea,NF2 shRNA,Genetic Reagent,,,,,,,,,,RES0c4385ea,,,,,,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.9,genetic_reagent
RES23ac5668,NF2 TET,Genetic Reagent,,,,,,,,,,RES23ac5668,,,,,,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,0.85,genetic_reagent
RES39306a69,nf2a/b-4sgRNA,Genetic Reagent,,,,,,,,,,RES39306a69,,,,,,PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,0.85,genetic_reagent
RES7ba0612d,S518A HA-Merlin,Genetic Reagent,,,,,,,,,,RES7ba0612d,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,genetic_reagent
RESe7247e8c,shNF1,Genetic Reagent,,,,,,,,,,RESe7247e8c,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,genetic_reagent
RESc85d1396,SPRED1,Genetic Reagent,,,,,,,,,,RESc85d1396,,,,,,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,0.85,genetic_reagent
RES66e53bd9,Spred1(EVH1),Genetic Reagent,,,,,,,,,,RES66e53bd9,,,,,,PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,0.85,genetic_reagent
RES467d7d57,Cutaneous neurofibroma samples,Patient-Derived Model,,,,,,,,,,,RES467d7d57,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,0.9,patient_derived_model
RES09dbe9c5,human neurofibroma xenografts,Patient-Derived Model,,,,,,,,,,,RES09dbe9c5,,,,,PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,0.9,patient_derived_model
RES16a23407,JH-2-002,Patient-Derived Model,,,,,,,,,,,RES16a23407,,,,,PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
RESdf3c4127,JH-2-031,Patient-Derived Model,,,,,,,,,,,RESdf3c4127,,,,,PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
RES0443ac87,JH-2-079c,Patient-Derived Model,,,,,,,,,,,RES0443ac87,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
RES0009d5c2,MN-2,Patient-Derived Model,,,,,,,,,,,RES0009d5c2,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
RES3bee3866,MN-3-002,Patient-Derived Model,,,,,,,,,,,RES3bee3866,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
RESdd3ae49a,MPNST-NF1-09,Patient-Derived Model,,,,,,,,,,,RESdd3ae49a,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
RESf0162f34,MPNST-SP-01,Patient-Derived Model,,,,,,,,,,,RESf0162f34,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
RES95850d8b,NF90.8,Patient-Derived Model,,,,,,,,,,,RES95850d8b,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,patient_derived_model
RES1c4e8ce2,Patient-derived xenograft (PDX) MPNST model,Patient-Derived Model,,,,,,,,,,,RES1c4e8ce2,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,patient_derived_model
RES8f664fbf,RHT-92,Patient-Derived Model,,,,,,,,,,,RES8f664fbf,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,patient_derived_model
RES458f9b63,vestibular schwannoma xenografts,Patient-Derived Model,,,,,,,,,,,RES458f9b63,,,,,PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,0.9,patient_derived_model
RES537ef440,WU-225,Patient-Derived Model,,,,,,,,,,,RES537ef440,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
RES9e22d7dd,WU-386,Patient-Derived Model,,,,,,,,,,,RES9e22d7dd,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
RES9e54235e,WU-545,Patient-Derived Model,,,,,,,,,,,RES9e54235e,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
